Brief: Lipidor Targets New Phase III Study Of AKP02 In 2024

Lipidor AB

26/05/2023 13:23

May 26 (Reuters) - Lipidor AB  LIPI.ST :
    * IS TARGETING A NEW PHASE III STUDY OF DRUG CANDIDATE AKP02
IN
2024

Source text for Eikon:  ID:nMFN4h4544 
Further company coverage:  LIPI.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))